1-8 of 8
Medha Sasane, BPharm, PhD
Close
Sort by
Journal Articles

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Wendy Y Cheng, MPH, MPhil, Agnihotram V Ramanakumar, PhD, Jonathan Fortier, MA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Patricia Adams-Graves, MD
Journal: Blood
Blood (2014) 124 (21): 2177.
https://doi.org/10.1182/blood.V124.21.2177.2177
Published: 2014
Journal Articles

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Francis Vekeman, MA, Wendy Y Cheng, MPH, MPhil, Medha Sasane, BPharm, PhD, Lynn Huynh, MPH, MBA, DrPH, Michael Kaminsky, BA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Ruben A. Mesa, MD
Journal: Blood
Blood (2013) 122 (21): 2964.
https://doi.org/10.1182/blood.V122.21.2964.2964
Published: 2013
Journal Articles

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

Morey A. Blinder, MD, Medha Sasane, BPharm, PhD, Jonathan Fortier, MA, Carole S. Paley, MD, Mei S. Duh, ScD, MPH, Francis Vekeman, MA
Journal: Blood
Blood (2013) 122 (21): 2927.
https://doi.org/10.1182/blood.V122.21.2927.2927
Published: 2013
Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2013) 122 (21): 982.
https://doi.org/10.1182/blood.V122.21.982.982
Published: 2013
Journal Articles

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Amer M. Zeidan, MD, Maria R. Baer, M.D., Steven D. Gore, MD, Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3178.
https://doi.org/10.1182/blood.V120.21.3178.3178
Published: 2012
Journal Articles

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Morey A. Blinder, MD, Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Alex Trahey, BS, Carole Paley, MD, Matthew Magestro, MBA, MS, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2012) 120 (21): 475.
https://doi.org/10.1182/blood.V120.21.475.475
Published: 2012
Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2012) 120 (21): 2106.
https://doi.org/10.1182/blood.V120.21.2106.2106
Published: 2012
Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 426.
https://doi.org/10.1182/blood.V120.21.426.426
Published: 2012